Dysregulation of PTP1B activity has been implicated in insulin resistance and T2D (18, 22) and inhibition of PTP1B improves insulin sensitivity, glucose uptake, and glucose homeostasis in preclinical models (18, 22). The gene discussed is INS; the disease is type 2 diabetes mellitus.